Skip to main content

Table 2 Susceptibility testing for key species

From: Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients

Capital region

Susceptibility for AMC

Isolates tested (percent sensitive)

Susceptibility for AMX

Isolates tested (percent sensitive)

H. influenzae

275 (97%)

273 (81%)

M. catarrhalis

133 (99%)

a

S. pneumoniae

109 (100%)

111 (94%)

Other

19 (79%)

53 (25%)

  1. a Should always be reported as R according to EUCAST